News
RHI Magnesita lowered its full-year profit guidance on Wednesday, after reporting a steep drop in earnings for the first half ...
Crystals and glasses have opposite heat-conduction properties, which play a pivotal role in a variety of technologies. These ...
Deutsche Bank downgraded Rio Tinto on Friday to 'hold' from 'buy' and cut its price target on the stock to 5,100p from 5,300p ...
1d
GlobalData on MSNBeOne Medicines’ BTK degrader gains EMA PRIME designationThe designation was based on the therapy’s novel mechanism and data showing its anti-tumour activity in B-cell malignancies.
ASTANA – Kazakhstan’s industrial production rose by 6.5% in the first six months of 2025, driven by an 8.4% increase in the mining sector and a 5.5% gain in manufacturing, reported the Kazakh Ministry ...
In the U.S., MONJUVI® (tafasitamab-cxix) is approved by the U.S. Food and Drug Administration in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or ...
It maintained its interim dividend at 60 euro cents per share, however. Looking ahead, RHI said it expects a "highly competitive pricing environment" to continue, amid pressures from China exporters ...
An expert discusses how the ZUMA-7 trial marked a pivotal shift in the treatment of primary refractory diffuse large B-cell ...
Second quarter 2025 revenues increased 4% to $3.68 billion versus second quarter 2024Dupixent® global net sales (recorded by Sanofi) increased 22% to $4.34 billion EYLEA HD® U.S. net sales increased ...
Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsDjaria Traore - Executive Vice President ...
Exciting new findings reveal that WASP-121b, a blazing-hot giant planet, may have formed far from its star in a colder, ice-rich region—before migrating inward to its current extreme orbit. Chemical f ...
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results